Atomoxetine and Methylphenidate Treatment in ADHD

Atomoxetine and Methylphenidate Treatment in ADHD

Objective: ADHD (Attention deficit/hyperactivity disorder) is the most common diagnosed neurobehavioral disorder in childhood and adolescence. Core symptoms of ADHD are persistent inattention, hyperactivity and impulsivity. In Slovakia, there are two specific medication choices to treat ADHD - atomo...

Full description

Bibliographic Details
Main Authors:	Snircova E., Hrtanek I., Kulhan T., Nosalova G., Ondrejka I.
Format:	Article
Language:	English
Published:	Sciendo 2015-05-01
Series:	Acta Medica Martiniana
Subjects:	attention deficit hyperactivity disorder atomoxetine methylphenidate cgi adhd-rs-iv
Online Access:	https://doi.org/10.1515/acm-2015-0003

Similar Items

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
by: Shiho Suzuki, et al.
Published: (2020-05-01)

A critical appraisal of atomoxetine in the management of ADHD
by: Childress AC
Published: (2015-12-01)

Is atomoxetine effective in some comorbid mental disorders in ADHD?
by: Cesneková D., et al.
Published: (2016-09-01)

Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis
by: Armagan Aral, et al.
Published: (2022-08-01)

Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders
by: Snircova E., et al.
Published: (2012-12-01)

Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01)

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report
by: Akın Tahıllıoğlu, et al.
Published: (2021-02-01)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
by: Yoko Nakanishi, et al.
Published: (2017-05-01)

Effect of anti‐attention‐deficit hyperactivity disorder (ADHD) medication on clinical seizures and sleep EEG: A retrospective study of Japanese children with ADHD
by: Hisako Yamamoto, et al.
Published: (2021-12-01)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
by: Huss M, et al.
Published: (2017-07-01)

Attention deficit hyperactivity disorder - symptoms, diagnosis and therapy among children and adults.
by: Agata Surowiec, et al.
Published: (2023-08-01)

Attention Deficit Hyperactivity Disorder and Methylphenidate: When Society Misunderstands Medicine
by: David D. Kaminester
Published: (2020-12-01)

The Knowledge and Attitude of the Parents of Children with ADHD toward Methylphenidate (Ritalin)
by: Sanaz Noroozi, et al.
Published: (2023-04-01)

Effectiveness and safety of atomoxetine for ADHD in population between 6 and 19 years: a systematic review
by: José Calleja, et al.
Published: (2012-09-01)

Effectiveness of methylphenidate and PUFA for the treatment of patients with ADHD: A double-blinded randomized clinical trial
by: Mahbobeh Firouzkouhi Moghaddam, et al.
Published: (2017-05-01)

Probable emergence of symptoms of trichotillomania by atomoxetine: a case report
by: Hamza Ayaydın
Published: (2019-04-01)

Effect of Methylphenidate on State Anxiety in Children With ADHD-A Single Dose, Placebo Controlled, Crossover Study
by: Maya Kritchman, et al.
Published: (2019-05-01)

A comparison of effectiveness of regulation of working memory function and methylphenidate on remediation of attention deficit hyperactivity disorder (ADHD).
by: Mohammad Reza Mohammadi, et al.
Published: (2014-03-01)

Is dopamine transporter gene effective on therapeutic response of methylphenidate in ADHD patients?
by: Fatemeh Moharrari, et al.
Published: (2015-04-01)

Is dopamine transporter gene effective on therapeutic response of methylphenidate in ADHD patients?
by: Fatemeh Moharrari, et al.
Published: (2015-01-01)

Atomoxetine associated red ear: A case report (eng)
by: Hande Ayraler Taner, et al.
Published: (2020-04-01)

Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
by: Inmyung Song, et al.
Published: (2016-10-01)

Methylphenidate-induced Psychotic Symptoms in 65-Year-Old Female with ADHD
by: Elliyeh Ghadrdan, et al.
Published: (2018-08-01)

Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report
by: Kosuke Okazaki, et al.
Published: (2019-03-01)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
by: Johanne Pereira Ribeiro, et al.
Published: (2021-08-01)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
by: Clemow DB, et al.
Published: (2017-02-01)

Effectiveness and safety of methylphenidate for ADHD in population between 6 and 19 years: a systematic review
by: José Calleja, et al.
Published: (2012-09-01)

Atomoxetine induced hypomania in a patient with bipolar disorder and adult attention deficit hyperactivity disorder
by: Vijaya Kumar, et al.
Published: (2017-01-01)

Atomoxetine Induced Obsessive-Compulsive Disorder
by: Mengühan Araz Altay
Published: (2019-01-01)

ADDH And Methylphenidate Response
by: J Gordon Millichap
Published: (1994-07-01)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
by: Onur İsmi, et al.
Published: (2018-07-01)

Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) – a pharmacoepidemiological and qualitative study
by: ICK Wong, et al.
Published: (2009-10-01)

Effects of methylphenidate on blood pressure, QT-interval, and cardiac output in ADHD diagnosed children: A three months’ follow-up study
by: Negar Omidi, et al.
Published: (2021-06-01)

Methylphenidate in Autism Spectrum Disorder: A Long-Term Follow Up Naturalistic Study
by: Patrizia Ventura, et al.
Published: (2020-08-01)

The Efficacy of Magnesium Supplementation in Children With Attention Deficit Hyperactivity Disorder under Treatment With Methylphenidate: A Randomized Controlled Trial
by: Seyed Gholamreza Noorazar, et al.
Published: (2021-01-01)

Possible Association between Methylphenidate and Mandibular Bone Characteristics Detected by Dental Panoramic Radiograph in Children and Adolescents with ADHD
by: Hadas Kostiner, et al.
Published: (2022-08-01)

Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD
by: Stéphanie Bioulac, et al.
Published: (2019-08-01)

Assessment of Adderall in ADHD
by: J Gordon Millichap
Published: (1998-05-01)

ABR and auditory P300 findings inchildren with ADHD
by: Eliane Schochat, et al.
Published: (2002-09-01)

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder
by: Serkan Turan, et al.
Published: (2019-10-01)